IMPELLA RP FX Trademark

Trademark Overview


On Wednesday, March 16, 2022, a trademark application was filed for IMPELLA RP FX with the United States Patent and Trademark Office. The USPTO has given the IMPELLA RP FX trademark a serial number of 97315360. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, February 21, 2023. This trademark is owned by Abiomed, Inc.. The IMPELLA RP FX trademark is filed in the Medical Instrument Products category with the following description:

implantable cardiac assist device, namely, blood pumps
impella rp fx

General Information


Serial Number97315360
Word MarkIMPELLA RP FX
Filing DateWednesday, March 16, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, February 21, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesimplantable cardiac assist device, namely, blood pumps

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbiomed, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDanvers, MA 01923

Trademark Events


Event DateEvent Description
Tuesday, February 21, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, February 21, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, February 21, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, August 8, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 8, 2022NON-FINAL ACTION E-MAILED
Monday, August 8, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 3, 2022ASSIGNED TO EXAMINER
Tuesday, March 22, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 19, 2022NEW APPLICATION ENTERED